We are live on ! Find out more
Arrowstreet Capital

Arrowstreet Capital Portfolio holdings

AUM $225B
1-Year Est. Return 49.49%
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
+49.49%
3 Year Est. Return
+172.58%
5 Year Est. Return
+223.9%
10 Year Est. Return
+876%
AUM
$63.2B
AUM Growth
+$8.84B
Cap. Flow
+$5.37B
Cap. Flow %
8.49%
Top 10 Hldgs %
21.75%
Holding
2,669
New
405
Increased
1,127
Reduced
686
Closed
375

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$1.82B
2
PG icon
Procter & Gamble
PG
+$458M
3
BA icon
Boeing
BA
+$445M
4
AAPL icon
Apple
AAPL
+$442M
5
MSFT icon
Microsoft
MSFT
+$377M

Sector Composition

Rank Sector Weight
1 Technology 25.95%
2 Consumer Discretionary 16.4%
3 Industrials 10.46%
4 Financials 9.69%
5 Healthcare 8.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HCCI
1901
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
$740K ﹤0.01%
55,453
+34,546
+165% +$524K
NPKI
1902
NPK International
NPKI
$1.18B
$736K ﹤0.01%
700,763
+35,704
+5% +$65.6K
CTMX icon
1903
CytomX Therapeutics
CTMX
$730M
$734K ﹤0.01%
110,346
+27,394
+33% +$203K
DAC icon
1904
Danaos Corp
DAC
$2.56B
$733K ﹤0.01%
99,889
+874
+0.9% +$4.17K
SNCR
1905
DELISTED
Synchronoss Technologies
SNCR
$731K ﹤0.01%
26,971
-3,903
-13% -$129K
DGICA icon
1906
Donegal Group Class A
DGICA
$696M
$730K ﹤0.01%
+51,904
New +$740K
ELV icon
1907
Elevance Health
ELV
$86.4B
$725K ﹤0.01%
+2,700
New +$726K
BLU
1908
DELISTED
BELLUS Health Inc.
BLU
$721K ﹤0.01%
+317,700
New +$901K
SFE
1909
DELISTED
Safeguard Scientifics, Inc.
SFE
$719K ﹤0.01%
131,133
ACIW icon
1910
ACI Worldwide
ACIW
$5.42B
$710K ﹤0.01%
+27,160
New +$752K
ARVN icon
1911
Arvinas
ARVN
$589M
$710K ﹤0.01%
30,054
-75,246
-71% -$2.18M
AT
1912
DELISTED
Atlantic Power Corporation
AT
$708K ﹤0.01%
359,772
-339,829
-49% -$691K
BKE icon
1913
Buckle
BKE
$2.31B
$707K ﹤0.01%
34,685
-176,286
-84% -$3.19M
GOEV
1914
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$705K ﹤0.01%
+138
New +$708K
PPC icon
1915
Pilgrim's Pride
PPC
$6.57B
$704K ﹤0.01%
47,013
-32,595
-41% -$521K
UMH
1916
UMH Properties
UMH
$1.42B
$704K ﹤0.01%
52,014
-46,917
-47% -$626K
GPX
1917
DELISTED
GP Strategies Corp.
GPX
$703K ﹤0.01%
72,965
-5,500
-7% -$48.6K
COLB icon
1918
Columbia Banking Systems
COLB
$9.18B
$701K ﹤0.01%
+29,400
New +$812K
GMLP
1919
DELISTED
Golar LNG Partners LP
GMLP
$699K ﹤0.01%
344,287
AUD
1920
DELISTED
Audacy, Inc.
AUD
$696K ﹤0.01%
432,038
+158,807
+58% +$238K
MPLX icon
1921
MPLX
MPLX
$59.6B
$693K ﹤0.01%
+44,055
New +$796K
MTUS icon
1922
Metallus
MTUS
$892M
$686K ﹤0.01%
193,133
+68,700
+55% +$264K
DOYU
1923
DouYu International Holdings
DOYU
$136M
$684K ﹤0.01%
5,180
-32,078
-86% -$4.6M
GHM icon
1924
Graham Corp
GHM
$1.3B
$683K ﹤0.01%
+53,465
New +$701K
INO icon
1925
Inovio Pharmaceuticals
INO
$93M
$683K ﹤0.01%
+4,908
New +$1.02M

Similar funds

Arrowstreet Capital's Q3 2020 Portfolio in Review

As of Q3 2020, Arrowstreet Capital held 2,669 positions worth $63.2B, up 16% from $54.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Arrowstreet Capital deployed $5.37B of net new capital in Q3 2020, opening 405 new positions and adding to 1,127 existing holdings. Its largest new stake was VanEck Russia ETF: 8,930,300 shares worth $187M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Alibaba, an estimated $1.18B trimmed.

  • Arrowstreet Capital's largest Q3 2020 buy was VanEck Russia ETF: 8,930,300 shares worth $187M.
  • Arrowstreet Capital added most to Amazon in Q3 2020, an estimated $1.82B increase.
  • Arrowstreet Capital's biggest Q3 2020 reduction was Alibaba, cutting an estimated $1.18B.
  • Arrowstreet Capital fully exited Medtronic in Q3 2020, selling an estimated $152M.
  • Arrowstreet Capital's ten largest holdings make up 22% of its $63.2B portfolio in Q3 2020.
  • Arrowstreet Capital opened 405 new positions and closed 375 in Q3 2020.
  • Arrowstreet Capital's portfolio value rose 16% quarter-over-quarter to $63.2B.

Based on Arrowstreet Capital's 13F filing for Q3 2020, filed 12 Nov 2020.